リポソームパクリタキセルの世界市場2020-2026:独立型、共用

QYResearchが発行した調査報告書(QYR20AP01324)
◆英語タイトル:Global Liposomal Paclitaxel Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP01324
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月(※2024年版があります。お問い合わせください。)
◆ページ数:116
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥725,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥1,087,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,450,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、リポソームパクリタキセルの世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、リポソームパクリタキセルのグローバル市場動向、メーカー別競争状況、種類別市場規模(独立型、共用)、用途別市場規模(病院、薬局)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・リポソームパクリタキセルの種類別市場2015-2026:独立型、共用
・リポソームパクリタキセルの用途別市場2015-2026:病院、薬局
・リポソームパクリタキセルの北米市場分析
・リポソームパクリタキセルのアジア市場分析
・リポソームパクリタキセルの中南米市場分析
・リポソームパクリタキセルの中東・アフリカ市場分析
・関連企業情報:Luye Pharma、CSPC Company
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

A form of the anticancer drug paclitaxel that is contained in very tiny, fat-like particles. It may have fewer side effects and work better than paclitaxel.In 2019, the global Liposomal Paclitaxel market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% during the forecast period. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Liposomal Paclitaxel.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Liposomal Paclitaxel market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Liposomal Paclitaxel market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Liposomal Paclitaxel market. Readers of the report can become informed about current and future trends of the global Liposomal Paclitaxel market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Liposomal Paclitaxel markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Liposomal Paclitaxel market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Liposomal Paclitaxel market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Liposomal Paclitaxel market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Liposomal Paclitaxel market is segmented into
Stand-alone Use
Joint Use

Market Segment by Application, the Liposomal Paclitaxel market is segmented into
Hospital
Drugs Store

This report includes the following manufacturers; we can also add the other companies as you want.
Luye Pharma
CSPC Company

The study objectives are:
To analyze and research the global Liposomal Paclitaxel status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Liposomal Paclitaxel manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Liposomal Paclitaxel are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Liposomal Paclitaxel Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Liposomal Paclitaxel Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Stand-alone Use
1.3.3 Joint Use
1.4 Market Segment by Application
1.4.1 Global Liposomal Paclitaxel Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Drugs Store
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Liposomal Paclitaxel Revenue (2015-2026)
2.1.1 Global Liposomal Paclitaxel Revenue (2015-2026)
2.1.2 Global Liposomal Paclitaxel Sales (2015-2026)
2.2 Liposomal Paclitaxel Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Liposomal Paclitaxel Sales by Regions (2015-2020)
2.2.2 Global Liposomal Paclitaxel Revenue by Regions (2015-2020)
2.3 Global Top Liposomal Paclitaxel Regions (Countries) Ranking by Market Size
2.4 Liposomal Paclitaxel Industry Trends
2.4.1 Liposomal Paclitaxel Market Top Trends
2.4.2 Market Drivers
2.4.3 Liposomal Paclitaxel Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Liposomal Paclitaxel Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Liposomal Paclitaxel Manufacturers by Sales (2015-2020)
3.1.1 Global Liposomal Paclitaxel Sales by Manufacturers (2015-2020)
3.1.2 Global Liposomal Paclitaxel Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Liposomal Paclitaxel Sales in 2019
3.2 Global Top Manufacturers Liposomal Paclitaxel by Revenue
3.2.1 Global Liposomal Paclitaxel Revenue by Manufacturers (2015-2020)
3.2.2 Global Liposomal Paclitaxel Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liposomal Paclitaxel Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liposomal Paclitaxel as of 2019)
3.4 Global Liposomal Paclitaxel Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Liposomal Paclitaxel Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Liposomal Paclitaxel Market
3.7 Key Manufacturers Liposomal Paclitaxel Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Liposomal Paclitaxel Historic Market Review by Type (2015-2020)
4.1.2 Global Liposomal Paclitaxel Sales Market Share by Type (2015-2020)
4.1.3 Global Liposomal Paclitaxel Revenue Market Share by Type (2015-2020)
4.1.4 Liposomal Paclitaxel Price by Type (2015-2020)
4.1 Global Liposomal Paclitaxel Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Liposomal Paclitaxel Sales Forecast by Type (2021-2026)
4.2.3 Global Liposomal Paclitaxel Revenue Forecast by Type (2021-2026)
4.2.4 Liposomal Paclitaxel Price Forecast by Type (2021-2026)

5 Global Liposomal Paclitaxel Market Size by Application
5.1 Global Liposomal Paclitaxel Historic Market Review by Application (2015-2020)
5.1.2 Global Liposomal Paclitaxel Sales Market Share by Application (2015-2020)
5.1.3 Global Liposomal Paclitaxel Revenue Market Share by Application (2015-2020)
5.1.4 Liposomal Paclitaxel Price by Application (2015-2020)
5.2 Global Liposomal Paclitaxel Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Liposomal Paclitaxel Sales Forecast by Application (2021-2026)
5.2.3 Global Liposomal Paclitaxel Revenue Forecast by Application (2021-2026)
5.2.4 Liposomal Paclitaxel Price Forecast by Application (2021-2026)

6 North America
6.1 North America Liposomal Paclitaxel Breakdown Data by Company
6.2 North America Liposomal Paclitaxel Breakdown Data by Type
6.3 North America Liposomal Paclitaxel Breakdown Data by Application
6.4 North America Liposomal Paclitaxel Breakdown Data by Countries
6.4.1 North America Liposomal Paclitaxel Sales by Countries
6.4.2 North America Liposomal Paclitaxel Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Liposomal Paclitaxel Breakdown Data by Company
7.2 Europe Liposomal Paclitaxel Breakdown Data by Type
7.3 Europe Liposomal Paclitaxel Breakdown Data by Application
7.4 Europe Liposomal Paclitaxel Breakdown Data by Countries
7.4.1 Europe Liposomal Paclitaxel Sales by Countries
7.4.2 Europe Liposomal Paclitaxel Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Liposomal Paclitaxel Breakdown Data by Company
8.2 Asia Pacific Liposomal Paclitaxel Breakdown Data by Type
8.3 Asia Pacific Liposomal Paclitaxel Breakdown Data by Application
8.4 Asia Pacific Liposomal Paclitaxel Breakdown Data by Regions
8.4.1 Asia Pacific Liposomal Paclitaxel Sales by Regions
8.4.2 Asia Pacific Liposomal Paclitaxel Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Liposomal Paclitaxel Breakdown Data by Company
9.2 Latin America Liposomal Paclitaxel Breakdown Data by Type
9.3 Latin America Liposomal Paclitaxel Breakdown Data by Application
9.4 Latin America Liposomal Paclitaxel Breakdown Data by Countries
9.4.1 Latin America Liposomal Paclitaxel Sales by Countries
9.4.2 Latin America Liposomal Paclitaxel Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Liposomal Paclitaxel Breakdown Data by Type
10.2 Middle East and Africa Liposomal Paclitaxel Breakdown Data by Application
10.3 Middle East and Africa Liposomal Paclitaxel Breakdown Data by Countries
10.3.1 Middle East and Africa Liposomal Paclitaxel Sales by Countries
10.3.2 Middle East and Africa Liposomal Paclitaxel Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Luye Pharma
11.1.1 Luye Pharma Corporation Information
11.1.2 Luye Pharma Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Luye Pharma Liposomal Paclitaxel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Luye Pharma Liposomal Paclitaxel Products and Services
11.1.5 Luye Pharma SWOT Analysis
11.1.6 Luye Pharma Recent Developments
11.2 CSPC Company
11.2.1 CSPC Company Corporation Information
11.2.2 CSPC Company Business Overview and Total Revenue (2019 VS 2018)
11.2.3 CSPC Company Liposomal Paclitaxel Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 CSPC Company Liposomal Paclitaxel Products and Services
11.2.5 CSPC Company SWOT Analysis
11.2.6 CSPC Company Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Liposomal Paclitaxel Sales Channels
12.2.2 Liposomal Paclitaxel Distributors
12.3 Liposomal Paclitaxel Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Liposomal Paclitaxel Sales Forecast (2021-2026)
13.1.1 Global Liposomal Paclitaxel Sales Forecast by Regions (2021-2026)
13.1.2 Global Liposomal Paclitaxel Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Liposomal Paclitaxel Sales Forecast (2021-2026)
13.2.2 North America Liposomal Paclitaxel Revenue Forecast (2021-2026)
13.2.3 North America Liposomal Paclitaxel Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Liposomal Paclitaxel Sales Forecast (2021-2026)
13.3.2 Europe Liposomal Paclitaxel Revenue Forecast (2021-2026)
13.3.3 Europe Liposomal Paclitaxel Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Liposomal Paclitaxel Sales Forecast (2021-2026)
13.4.2 Asia Pacific Liposomal Paclitaxel Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Liposomal Paclitaxel Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Liposomal Paclitaxel Sales Forecast (2021-2026)
13.5.2 Latin America Liposomal Paclitaxel Revenue Forecast (2021-2026)
13.5.3 Latin America Liposomal Paclitaxel Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Liposomal Paclitaxel Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Liposomal Paclitaxel Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Liposomal Paclitaxel Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

...

【掲載企業】

Luye Pharma、CSPC Company

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ リポソームパクリタキセルの世界市場2020-2026:独立型、共用(Global Liposomal Paclitaxel Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。